INDIVIOR INC. v. MYLAN TECHNOLOGIES INC.

Civil Action No. 15-1016-RGA.

232 F.Supp.3d 650 (2017)

INDIVIOR INC., Indivior UK Limited, and Monosol RX, LLC, Plaintiffs, v. MYLAN TECHNOLOGIES INC., Mylan Pharmaceuticals Inc., and Mylan N.V., Defendants.

United States District Court, D. Delaware.

Signed January 12, 2017.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER


Attorney(s) appearing for the Case

Daniel M. Attaway, Esq. , WOMBLE CARLYLE SANDRIDGE & RICE, LLP, Wilmington, Delaware; Daniel A. Ladow, Esq. (argued), J. Magnus Essunger, Esq. , TROUTMAN SANDERS LLP, Atlanta, Georgia; Jeffrey B. Elikan, Esq. , COVINGTON & BURLING LLP, Washington. D.C.; Cassandra A. Adams, Esq. , STEPTOE & JOHNSON LLP, New York, New York, Attorneys for Plaintiffs.

Bindu A. Palapura, Esq. , POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; David M. Hanna, Esq. , WILSON SONSINI GOODRICH & ROSATI, San Francisco, California. Elham Firouzi Steiner, Esq. (argued), WILSON SONSINI GOODRICH & ROSATI, San Diego, California, Attorneys for Defendant.


MEMORANDUM OPINION

Presently before me is the issue of claim construction of multiple terms in U.S. Patent No. 8,603,514 (the "'514 Patent"), U.S. Patent No. 8,475,832 (the "'832 Patent"), U.S. Patent No. 8,017,150 (the "'150 Patent"), and U.S. Patent No. 8,900,497 (the "'497 Patent...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases